TB Research

Antitubercular and anti-inflammatory properties screening of natural products from Plectranthus species

Andrade JM, Custódio L, Romagnoli A, Reis CP, Rodrigues MJ, Garcia C, Petruccioli E, Goletti D, et al. (11 authors)

Future medicinal chemistry · 2018-06

Abstract

Aim Confirm the use of Plectanthus spp. plants in traditional medicine, particularly as anti-inflammatory and anti-infective agents. Materials & methods Compounds previously isolated from Plectranthus spp. were studied for their anti-inflammatory activity using the SNAP assay and RAW 264.7 cells, by the quantification of nitric oxide. An halimane diterpene and its derivatives were tested in infected macrophages with M. tuberculosis H37Rv, using CFU counts assay, at their minimum inhibitory concentration values. Results: The isolated compounds tested at noncytotoxic concentrations, did not reveal nitric oxide scavenging in the S-nitroso-N-acetylpenicillamine and the cellular assays. On the other hand, promising results were obtained regarding one semisynthetic halimane derivative (11R*,13E)-halima-5,13-diene-11,15-diol), previously prepared (2.1 × 10 5 CFU/mL), with an effect similar to the antitubercular drugs ethambutol (2.0 × 10 5 CFU/mL) and isoniazid (1.2 × 10 5 CFU/mL). Conclusion The present report demonstrates the relevance of Plectranthus spp. in medicinal chemistry drug development for TB and other infective respiratory complaints. Also, this work suggests that further studies involving other inflammatory mediators are needed to validate the anti-inflammatory use of these medicinal plants.

MeSH terms

  • Leukocytes, Mononuclear
  • Macrophages
  • Animals
  • Mice
  • Mycobacterium tuberculosis
  • Plectranthus
  • Plants, Medicinal
  • Nitric Oxide
  • Lipopolysaccharides
  • Anti-Inflammatory Agents
  • Biological Products
  • Antitubercular Agents
  • Microbial Sensitivity Tests
  • Cell Survival
  • RAW 264.7 Cells